# GI Permeability Change in Response to Aquamin®

> **NCT04855799** · PHASE2 · COMPLETED · sponsor: **James Varani** · enrollment: 33 (actual)

## Conditions studied

- Ulcerative Colitis
- Healthy
- Irritable Bowel Syndrome With Diarrhea

## Interventions

- **DRUG:** Aquamin

## Key facts

- **NCT ID:** NCT04855799
- **Lead sponsor:** James Varani
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-02
- **Primary completion:** 2024-03-11
- **Final completion:** 2024-03-25
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04855799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04855799, "GI Permeability Change in Response to Aquamin®". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04855799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*